These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9518688)

  • 61. Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs.
    Fehér E; Szatmári I; Dudás T; Zalatnai A; Farkas T; Lőrinczi B; Fülöp F; Vécsei L; Toldi J
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31561643
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
    Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
    J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kynurenic acid attenuates NMDA-induced pial arteriolar dilation in newborn pigs.
    Bari F; Nagy K; Guidetti P; Schwarcz R; Busija DW; Domoki F
    Brain Res; 2006 Jan; 1069(1):39-46. PubMed ID: 16388784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. On the toxicity of kynurenic acid in vivo and in vitro.
    Turski WA; Małaczewska J; Marciniak S; Bednarski J; Turski MP; Jabłoński M; Siwicki AK
    Pharmacol Rep; 2014 Dec; 66(6):1127-33. PubMed ID: 25443745
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.
    Nozaki K; Beal MF
    J Cereb Blood Flow Metab; 1992 May; 12(3):400-7. PubMed ID: 1569135
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cortical spreading depression augments kynurenate levels and reduces malonate toxicity in the rat cortex.
    Kiss C; Shepard PD; Bari F; Schwarcz R
    Brain Res; 2004 Mar; 1002(1-2):129-35. PubMed ID: 14988042
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents.
    Battaglia G; La Russa M; Bruno V; Arenare L; Ippolito R; Copani A; Bonina F; Nicoletti F
    Brain Res; 2000 Mar; 860(1-2):149-56. PubMed ID: 10727634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus.
    Moroni F; Cozzi A; Carpendo R; Cipriani G; Veneroni O; Izzo E
    Neuropharmacology; 2005 May; 48(6):788-95. PubMed ID: 15829251
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro and in vivo effects of ammonia on glucose metabolism in the astrocytes of rat cerebral cortex.
    Ratnakumari L; Murthy CR
    Neurosci Lett; 1992 Dec; 148(1-2):85-8. PubMed ID: 1300509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo neuroprotective effects of peripheral kynurenine on acute neurotoxicity induced by glutamate in rat cerebral cortex.
    Kumar A; Babu GN
    Neurochem Res; 2010 Apr; 35(4):636-44. PubMed ID: 20035383
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93).
    Wejksza K; Rzeski W; Okuno E; Kandefer-Szerszen M; Albrecht J; Turski WA
    Neurochem Res; 2005 Aug; 30(8):963-8. PubMed ID: 16258845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kynurenic acid synthesis by human glioma.
    Vezzani A; Gramsbergen JB; Versari P; Stasi MA; Procaccio F; Schwarcz R
    J Neurol Sci; 1990 Oct; 99(1):51-7. PubMed ID: 2250171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor.
    Wejksza K; Rzeski W; Parada-Turska J; Zdzisinska B; Rejdak R; Kocki T; Okuno E; Kandefer-Szerszen M; Zrenner E; Turski WA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Mar; 369(3):300-4. PubMed ID: 14770276
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro.
    Scharfman HE; Goodman JH; Schwarcz R
    Amino Acids; 2000; 19(1):283-97. PubMed ID: 11026500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. (R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats.
    Speciale C; Wu HQ; Cini M; Marconi M; Varasi M; Schwarcz R
    Eur J Pharmacol; 1996 Nov; 315(3):263-7. PubMed ID: 8982663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Behavioural studies with a newly developed neuroprotective KYNA-amide.
    Gellért L; Varga D; Ruszka M; Toldi J; Farkas T; Szatmári I; Fülöp F; Vécsei L; Kis Z
    J Neural Transm (Vienna); 2012 Feb; 119(2):165-72. PubMed ID: 21818601
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fate and distribution of kynurenic acid administered as beverage.
    Turska M; Pelak J; Turski MP; Kocki T; Dukowski P; Plech T; Turski W
    Pharmacol Rep; 2018 Dec; 70(6):1089-1096. PubMed ID: 30308459
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brain-specific modulation of kynurenic acid synthesis in the rat.
    Gramsbergen JB; Hodgkins PS; Rassoulpour A; Turski WA; Guidetti P; Schwarcz R
    J Neurochem; 1997 Jul; 69(1):290-8. PubMed ID: 9202322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats.
    Żarnowski T; Chorągiewicz T; Tulidowicz-Bielak M; Thaler S; Rejdak R; Żarnowski I; Turski WA; Gasior M
    J Neural Transm (Vienna); 2012 Jun; 119(6):679-84. PubMed ID: 22200857
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.
    Olsson SK; Larsson MK; Erhardt S
    J Neural Transm (Vienna); 2012 Feb; 119(2):155-63. PubMed ID: 21904895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.